Detalhe da pesquisa
1.
Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN PACE Trial (Patients With Intermittent Claudication Injected With ALDH Bright Cells).
Circulation
; 135(15): 1417-1428, 2017 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28209728
2.
Factors affecting the turnaround time for manufacturing, testing, and release of cellular therapy products prepared at multiple sites in support of multicenter cardiovascular regenerative medicine protocols: a Cardiovascular Cell Therapy Research Network (CCTRN) study.
Transfusion
; 52(10): 2225-33, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22320233
3.
Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial.
JAMA
; 307(16): 1717-26, 2012 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-22447880
4.
Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial.
JAMA
; 308(22): 2380-9, 2012 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-23129008
5.
Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial.
JAMA
; 306(19): 2110-9, 2011 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-22084195
6.
A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trial.
Eur J Heart Fail
; 23(4): 661-674, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33811444
7.
Multicenter cell processing for cardiovascular regenerative medicine applications: the Cardiovascular Cell Therapy Research Network (CCTRN) experience.
Cytotherapy
; 12(5): 684-91, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20524773
8.
Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients: The CCTRN SENECA Trial.
JACC CardioOncol
; 2(4): 581-595, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33403362